Tirzepatide with B12 dosage and evidence
Written by Aaron CuhaReviewed Sep 2026
The short answer
Here there is a published chemistry reason not to mix.
Evidence grade for Tirzepatide with B12: Limited. The rule: people have taken it in a published study, but fewer than 100 of them. The sum on this page: 2 completed trials, none stating how many people. A grade counts how much has been done to people, not whether it works.
- People given it
- 0
- Human studies
- 2
- Found nothing
- 0
Dose
No human dose established
Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose.
2 completed trials, 0 people given it
6 effects reported, 4 unwanted, 2 wanted, by people using it, not a trial
Goal pages: Fat loss and metabolism
In plain English
In plain English, from Aaron
This is how I would explain it to a friend. The evidence, with the numbers, is further down the page.
This is compounded tirzepatide with vitamin B12 mixed in. It is the one blend on this site where somebody actually tested the chemistry, and they found a problem. Mixing the two makes a new substance that was not supposed to be there.
What people take it for
- Losing weight.
- Less nausea from the shot.
- More energy.
What studies in people showed
No one has tested the mix in a person. But a lab did test the liquid. They bought compounded tirzepatide and B12 products from several places in the US market and ran them through their machines. They found a widespread impurity nobody had seen before. It comes from a chemical reaction between the tirzepatide and certain forms of B12. What that impurity does in a body is unknown, and the paper says so plainly. One thing you should know. The people who ran those tests all work for Eli Lilly, which sells the brand name tirzepatide and competes with compounders. That is a real conflict and it is printed in the paper. It is also the only chemistry anyone has published on these mixes, and nobody has published anything that disagrees. The tirzepatide half on its own is strong. In SURMOUNT-1, people lost 20.9 percent of their body weight on the top dose over 72 weeks, against 3.1 percent on a dummy shot. The math: a common vial is 20 mg per mL tirzepatide with 0.5 mg per mL B12. A 5 mg dose is a quarter of a mL, which carries 125 micrograms of B12.
What people report
Reports, not study results
The good
- Hunger goes quiet.
- Weight comes off fast.
The bad
- Nausea, constipation and reflux.
- Sulphur burps and feeling full too early.
- People got nervous when the impurity finding went public and moved back to single ingredient vials.
- Nobody tests these vials for strength or purity before they are sold, so you do not know what is in yours.
Where these come from: The stomach side effects come from the trial tables. The rest comes from patient forums and is just people talking. The impurity finding is a published lab study and is listed on this page.
My bottom line
Somebody looked at this one, and what they found was a reaction nobody can explain the effects of. The conflict of interest is real and so is the chemistry. I would take the vitamin separately.
An opinion, not a finding. I am a coach, not a doctor.
What it has been measured to do
Measured in people
Goals Tirzepatide with B12 has been tested for in people, biggest studies first. We count only what the studies on this page say, so the real numbers may be higher.
- Losing weightno headcount stated · 1 study
What people using it report
Real people telling you what happened to them. Nobody checked it, and the people who post are not a fair sample, so it cannot prove anything works. It is still the best guide on this page to what people actually do with Tirzepatide with B12, what they expect, and what goes wrong. The full account, including the negative reports, is below.
34 of the 36 indexed goals have no study of any kind behind Tirzepatide with B12
No study in people, animals or cells on this page reports a result for these. That does not prove Tirzepatide with B12 does nothing for them. It does mean anything you have heard about Tirzepatide with B12 and one of these did not come from a study cited here.
Show full evidence
What is Tirzepatide with B12?
Here there is a published chemistry reason not to mix. Lab tests of pharmacy-made tirzepatide plus B12, from many sources, found a new unwanted chemical in many products. It forms when the peptide reacts with some forms of B12. The tests were done by the maker of the branded drug, which is a stated conflict of interest. It is the only published chemistry on these mixes.
Most pages in this section have to say nobody has looked. This one is different. Somebody looked, and they found something.
Samples of pharmacy-made tirzepatide mixed with B12 were bought from different sources in the US. They were run through several lab tests to look for unwanted chemicals linked to the peptide. The tests found a new unwanted chemical in many of them. Nobody had spotted it before. It forms when tirzepatide reacts with some forms of vitamin B12. The authors work for Eli Lilly, which makes branded tirzepatide and has a clear money interest in the pharmacy market. The paper says so, and that conflict is real. It is still not a reason to ignore the result. The finding is a lab measurement, not an opinion. And nobody has published a test that says otherwise.
What nobody knows is what the new chemical does. The paper says its effects in people are unknown. That covers whether it changes how the drug works, whether it is toxic, whether it sets off the immune system, and how the body takes it up and clears it. That is an honest list of unknowns. It is also exactly the problem. An untested molecule in real amounts in a weekly shot is not just a theory.
The math on a common multi-dose mix: tirzepatide 20 mg/mL with B12 at 0.5 mg/mL, in a 5 mL vial. A 5 mg tirzepatide dose is 0.25 mL, with 125 micrograms of B12. A 2.5 mg starting dose is 0.125 mL, with 62.5 micrograms. The B12 is 2.5% of the tirzepatide by weight at every dose. So once again the vitamin amount is set by the weight loss drug dose, not by anything about the person taking it.
The tirzepatide half has strong evidence in people. In the big SURMOUNT-1 study, average weight loss at 72 weeks was 15.0% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg. On the dummy shot it was 3.1%. On 15 mg, 57% of people lost 20% or more of their body weight, against 3% on the dummy. That study used tirzepatide alone.
How does Tirzepatide with B12 work?
Tirzepatide copies two gut hormones, GIP and GLP-1. It turns down appetite and slows how fast the stomach empties. B12 is a vitamin used to fix a shortage. The key fact on this page is not what either drug does. It is the reaction between them. Lab work found a new chemical made from the peptide and some forms of B12 sitting in the same liquid.
What have studies in people found about Tirzepatide with B12?
No study of the premix in people. Tirzepatide alone has large studies in people. The new chemical has no data in people at all, and that is the whole worry.
- Tirzepatide alone: average weight loss of 20.9% on 15 mg at 72 weeks, against 3.1% on a dummy shot.
- B12 top-ups: bring blood levels back to normal in over 90% of people who are short of it, by eight weeks.
- The premix: no published study in people and no listed trial.
- The new chemical: found by lab tests in products from many sources. The paper says plainly that its effects in people are unknown.
What this does not tell you: Nobody has measured what the new chemical does in a person, to how the drug works, to the immune system, or over time. That is not comforting. It is the reason the finding was published.
What do people who took Tirzepatide with B12 report?
This is what real people say happened to them, good and bad. Nobody measured it. A report cannot tell a real effect from the lift people get just from expecting it to work, from a diet or training change made at the same time, or from what was really in the vial. We still put it near the top. It is the next best thing to a study in people: what happens when real people use it, including what goes wrong.
- Feeling sick, constipation and reflux, the same pattern as the branded drug.
- Sulphur burps and feeling full early.
- A pink or red tint to the liquid from the B12, which people use to spot the product.
- No difference felt from pharmacy-made versions without B12.
- Worry after the lab finding made the news, and a move back to vials with just one ingredient.
Sources: Trial side-effect tables for the gastrointestinal pattern. The rest from forums including r/tirzepatidecompound and telehealth patient communities, uncontrolled and self-reported.
The state of the research
Two things are true here, and they pull in opposite directions. The chemistry finding is real, published, checked by other scientists, and not disproved. It was also written only by staff of the company whose branded drug competes with the pharmacy market. That company has sued and campaigned against pharmacies that make these drugs. Both facts belong on the page. The right answer to a conflicted finding is for someone independent to repeat the test. Nobody has published one.
The second point is why the vitamin is there at all. On the semaglutide side, the reasons given are nausea and energy, and neither has a study. On the tirzepatide side the same reasons are given, plus a legal one. A mix with an added ingredient is not an exact copy of an approved drug. If that is the real reason, then the patient carries an unmeasured chemical risk for the sake of a legal shortcut.
The evidence, in charts
Fig. 1a · how many people
2studies in people cited, but none says how many people took part
number of people not stated
We do not draw a total, because none of the studies in people on this page gives one. Read the sources below for what each study measured.
We read the number of people from the source lines on this page. Where a line gives no number, we count nothing for it. We do not guess.
Fig. 1b · evidence mix
2 of 4 sources here are studies in people. The rest are not.
- Study in people · done in people250%
- Lab (cells in a dish) · cells or tissue125%
- Review of studies · sums up other studies125%
Counted from the list of sources on this page. It counts only what we cite, so there may be more studies out there. A review counts once, however many studies it sums up.
Fig. 2 · evidence over time
The studies cover 3 different years, 2020 to 2026, counted from the list of sources on this page.
Fig. 3 · legal status at a glance
US
Not approved
UK
Not approved
AU
Not approved
CA
Not approved
Not approved in any of the four countries shown. This is what the law says, not a verdict on the science. See Legal status below for the full text and any notes.
Fig. 4 · how much does what
Nobody has tested different amounts in people
This chart would show how the effect changes as the amount goes up. For this compound, nobody has measured that in people. So we leave it empty. We will not borrow an animal chart and pretend it works the same in people.
Fig. 5 · what the molecule is
- Kind of compound
- Blend
- Molecule weight
- Not on file
- Half-life
- Stated in words, not a numbersee the exact wording below
- Chain length
- None on file
Half-life as stated on file: Not defined for the mixture. The incretin component supports weekly dosing; no pharmacokinetic study of the premix has been published, and the impurity's behaviour is unknown.
No amino acid sequence is on file for Tirzepatide with B12, which is expected: a blend is not built from amino acids.
Fig. 6 · what is in the vial
We cannot show how much of each is in this blend
Sellers do not agree on a vial size for Tirzepatide with B12, so nobody outside can know how much of each ingredient is in it. Splitting the bar evenly would make up the very number this page is here to question.
- TirzepatideStrong. At least two finished studies in people, and at least 1,000 people who took it. 9 completed trials, 22,802 people given it.amount not stated
- CyanocobalaminLimited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people.amount not stated
Ingredient list from the product labels we have. Amounts are what the label says is in the vial, never a dose.
The studies we cite
- Study in people2022Tirzepatide Once Weekly for the Treatment of Obesity
Tirzepatide caused very large weight loss in a big study. Adults took a weekly shot at one of three strengths, or a dummy shot, for about 17 months. Average weight fell 15.0%, 19.5% and 20.9% as the dose went up, against 3.1% on the dummy. On the top dose, 57 in every 100 people lost at least a fifth of their body weight, against 3 in 100. Stomach and bowel upsets were the common complaint, mostly mild. No vitamin was given with it.
SURMOUNT-1. Mean percentage weight change at week 72 was 15.0% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg weekly, against 3.1% on placebo. 57% of the 15 mg group lost 20% or more of body weight against 3% on placebo. Gastrointestinal events were the most common adverse events and were mostly mild to moderate. Tirzepatide alone, with no vitamin co-administered.
- Study in people2020Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomised, non-inferiority clinical trial (OB12)
Swallowing B12 works as well as injecting it, in people shown to be short of it. People with a proven shortage got either pills or shots into the muscle. After eight weeks both ways had brought blood levels back to normal in well over nine in ten. That is what the B12 evidence is about. It is topping up people whose blood test came back low. It is not a boost for people whose levels are already fine.
In patients with documented deficiency, oral and intramuscular B12 both normalised serum B12 in well above 90% of patients at eight weeks. B12 evidence is replacement evidence in tested, deficient people.
- Review of studies2026FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
This is the FDA's warning about pharmacy-made and other unapproved GLP-1 drugs. It covers reports of harm, dosing mistakes, and the fact that the FDA does not check these drugs for safety, whether they work, or quality.
FDA's statement on compounded and other unapproved GLP-1 products, covering adverse event reports, dosing errors and the absence of agency review for safety, effectiveness or quality.
- Lab (cells in a dish)2026A novel, widespread impurity in mass-compounded tirzepatide/B12 products: potential patient safety implications
This is a lab test, not a study in people. Pharmacy-made tirzepatide plus B12 was bought from many US sources and run through several lab tests. The testers found a new unwanted chemical in many of the samples. It forms when tirzepatide reacts with some forms of B12. The paper says nobody knows what it does in the body. All five authors work for Eli Lilly, which sells branded tirzepatide. The paper says so.
Compounded tirzepatide plus B12 samples from various US market sources were tested by several analytical methods and assessed for peptide-related impurities. Testing identified a widespread, previously unidentified impurity resulting from a chemical reaction between tirzepatide and certain B12 analogues. The paper states that the clinical effects of the impurity are unknown. All five authors are Eli Lilly employees, disclosed in the paper, and Lilly markets the branded tirzepatide.
Where to buy Tirzepatide with B12
No seller we track lists Tirzepatide with B12 yet. We read sellers’ public product lists every week, and this section fills in as soon as one does. Every seller, graded
Common questions
Has Tirzepatide with B12 been tested in people?
Yes. 0 people given it across 2 completed trials cited here, 0 of which found nothing. Here there is a published chemistry reason not to mix.
What is the Tirzepatide with B12 dosage?
No human dose established. Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose. 2 completed trials, 0 people given it
Is Tirzepatide with B12 FDA-approved?
Not an approved product. Pharmacy-mixed (compounded) products are not FDA approved. They are not checked for safety, for whether they work, or for quality. The FDA has published long-standing concerns about unapproved GLP-1 products sold for weight loss.
Is there actually something wrong with mixing tirzepatide and B12?
Published lab tests of products on the market found a new unwanted chemical in many of them. It forms when tirzepatide reacts with some forms of B12. Nobody knows what it does in a person, and the paper says so.
Who did that testing?
Staff of Eli Lilly, and the paper says so. Lilly sells the branded tirzepatide and competes with pharmacies that make it. That conflict is real and should be weighed. Nobody independent has published a repeat of the test. Nobody has published a test that disagrees, either.
How much B12 is in my dose?
On a common mix of 20 mg/mL tirzepatide with 0.5 mg/mL B12, a 5 mg dose is 0.25 mL and holds 125 micrograms of B12. The vitamin is 2.5% of the peptide by weight at every dose. So the amount follows your tirzepatide dose, not your B12 level.
Should I switch to a single-ingredient vial?
That version has one less unknown in it. This page does not give medical advice, and the choice is yours to make with your prescriber. But ask why the vitamin is in there before you accept the chemical reaction that comes with it.
Does the tirzepatide still work in these preparations?
Pharmacy-made products are not tested for strength or unwanted chemicals before they are sold. So the honest answer is that nobody outside the pharmacy knows what is in a given vial. The 20.9% weight loss number people quote comes from a study of the approved drug.